Title of article :
Imatinib mesylate-related and dasatinib-related adverse effects in a case with chronic myeloid leukemia
Author/Authors :
yokuş, osman ministry of health - istanbul training and research hospital - department of hematology, turkey , gedik, habip ministry of health - bakırköy sadi konuk training and research hospital - department of infectious diseases and clinical microbiology, Turkey , aslan, ceyda ministry of health - istanbul training and research hospital - department of hematology, Turkey
Abstract :
First-generation and second-generation tyrosine kinase inhibitors have marked an era in the treatment of chronic myeloid leukemia. In this case report, diffuse skin lesions and pleural effusions developed after administration of imatinib in a patient with chronic myeloid leukemia. Skin reactions may develop due to imatinib mesylate use often within the first 2 months. In this case, the drug is continued, switching to a different second-generation tyrosine kinase inhibitors.
Keywords :
adverse effect , chronic myeloid leukemia , imatinib mesylate , tyrosine kinase inhibitors
Journal title :
The Egyptian Journal of Haematology
Journal title :
The Egyptian Journal of Haematology
